Los Angeles, CANCT07298135Now EnrollingIRB Ready

Blood Glucose Control Clinical Trial in Los Angeles, CA

Access cutting-edge blood glucose control treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Olipop, PBC

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access blood glucose control specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related blood glucose control treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this blood glucose control clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Blood Glucose Control Study in Los Angeles

The main objective of this study is to evaluate the chronic effects of replacing traditional non-diet soda with a prebiotic soda on biomarkers associated with glycemic control in adults with glucose dysregulation who are habitual consumers of traditional soda.

Sponsor: Olipop, PBC

Who Can Participate

Inclusion Criteria

Able to provide informed consent
Willing to comply with all study procedures
Male or female, ages 30 - 70 years old
Habitual consumers of traditional non-diet soda (average intake 2 - 3 servings (24-36 fl. oz)/daily in a typical month, representing usual dietary pattern)
BMI between 25 - 35 kg/m²
Fasting plasma glucose between 100 - 125 mg/dL or hemoglobin A1c between 5.7% - 6.4%
Low habitual dietary fiber intake, assessed using a qualitative fiber intake screening questionnaire administered at pre-screening
Willing to maintain stable tobacco/nicotine use habits established for ≥ 90 days, with no initiation, cessation, or change in frequency during the study period
Willing to maintain stable marijuana, hemp, and CBD product use habits established for ≥ 60 days, with no initiation, cessation, or change in frequency during the study period
Willing to maintain habitual diet (with the exception of study products) and physical activity patterns throughout the trial

Exclusion Criteria

Inability to consume a standard 12 fl. oz. carbonated beverage twice daily
Currently engaged or planning to be on an intensive weight loss regimen program
Extreme dietary habits in the judgement of the Investigator or has been diagnosed with an eating disorder
Habitual use of fiber supplements, inulin-based supplements, acacia fiber, glucomannan, prebiotic supplements, or probiotic supplements within 30 days of study enrollment
Known allergy or sensitivity to any of the ingredients in the study products
History or presence of uncontrolled and/or clinically important medical conditions that could interfere with study results interpretation (i.e., diabetes mellitus, CKD stage 4-5, severe liver disease/cirrhosis, uncontrolled hypertension, recent myocardial infarction or stroke (within 6 months), severe mental illness or cognitive impairment, immunodeficiency disorders, active infections).
Gastrointestinal conditions that could potentially interfere with absorption of the study product (i.e., IBD, celiac disease, short bowel syndrome, chronic pancreatitis, gastroparesis, active peptic ulcer disease, gastric bypass or other bariatric surgeries, severe IBS, chronic diarrhea or malabsorption syndromes, active diverticulitis)
Use of oral or injectable steroids within 90 days of enrollment
Use of antibiotic therapy within 90 days of enrollment
Unstable use of prescription medications within 90 days of enrollment that affect plasma glucose levels (e.g., corticosteroids, thiazide diuretics, beta-blockers (some types), antipsychotics, tacrolimus, protease inhibitors, ACE inhibitors)
Use of any of the following prescription medications within 90 days of enrollment: Metformin, sulfonylureas, GLP-1 agonists, SGLT-2 inhibitors, insulin.
History or presence of cancer, except non-melanoma skin cancer, within 2 years of enrollment
Exposure to any non-registered drug product or participation in another intervention study within 30 days prior to enrollment
Recent history (within 12 months) of alcohol or substance abuse
History of major trauma or surgical event within 60 days of enrollment
Person who is pregnant, planning pregnancy, or lactating
Any condition the Investigator believes would interfere with study participation or compliance
Consumption of more than 5 prebiotic sodas within the last 30 days prior to enrollment
Heavy smoker as defined as smoking 20 or more cigarettes per day, or smoked roughly 1 pack a day for 20+ years (more than 20 pack years)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT07298135) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Blood Glucose Control Treatment Options in Los Angeles, CA

If you're searching for blood glucose control treatment options in Los Angeles, CA, this clinical trial (NCT07298135) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood glucose control specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all blood glucose control clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Los Angeles, CA

See all ulcerative colitis clinical trials recruiting in Los Angeles — not just this study.

Browse Ulcerative Colitis Trials in Los Angeles →

Browse More Trials by Condition

Ulcerative Colitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA